Socrates E. Papapoulos

28.3k citations
303 papers · 17.5k indexed · 4 hit papers · h-index 73

Impact in

Papers in

Socrates E. Papapoulos

298 papers receiving 16.9k citations

Hit Papers

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension 2017 · 662 citations
6622002202620102018200400600

Peers

Socrates E. Papapoulos
Comparison fields: 5 of 158
  • Orthopedics and Sports Medicine 7.3k
  • Oncology 9.2k
  • Nephrology 1.2k
  • Rheumatology 1.9k
  • Molecular Biology 7.3k
Replace Erik Fink Eriksen with:
Erik Fink Eriksen Denmark
Lorenz C. Hofbauer Germany
David L. Lacey United States
Paul D. Miller United States
T. John Martin Australia
David W. Dempster United States
Patrick Garnero France
Brendan F. Boyce United States
Marc K. Drezner United States
Lorraine A. Fitzpatrick United States
Socrates E. Papapoulos relative to Erik Fink Eriksen Denmark Erik Fink Eriksen's profile →
Citations per field
00.5×1.7×
Erik Fink Eriksen · 1×
Citations per year

Countries citing papers authored by Socrates E. Papapoulos

Since Specialization
Citations

This map shows the geographic impact of Socrates E. Papapoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Socrates E. Papapoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Socrates E. Papapoulos more than expected).

Fields of papers citing papers by Socrates E. Papapoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Socrates E. Papapoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Socrates E. Papapoulos. The network helps show where Socrates E. Papapoulos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Socrates E. Papapoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Socrates E. Papapoulos Line = papers co-authored together Socrates E. Papapoulos links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20221
2 20215
3 202143
4 202010
5 2018129
6
TEN YEARS OF DENOSUMAB (DMAB) TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FREEDOM EXTENSION TRIAL
20161
7
Denosumab treatment in postmenopausal women with osteoporosis for up to 9 years: results through year 6 of the freedom extension
20152
8
Evolution of subject characteristics in FREEDOM and its extension for up to 8 years
20152
9
EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION
201412
10
Relationship Between Changes in Bone Mineral Density and Incidence of Fracture with 6 Years of Denosumab Treatment
20121
11
Treatment of postmenopausal women with osteoporosis for six years with denosumab : three-year results from the freedom extension
20121
12
DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR 6 YEARS: RESULTS FROM THE FIRST 3 YEARS OF THE FREEDOM EXTENSION
20122
13
Safety observations from denosumab long-term extension and cross-over studies in postmenopausal women with osteoporosis
20113
14
FIVE-YEAR DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION
20119
15
Long-term denosumab treatment of postmenopausal women with osteoporosis: results from the first year extension study of the FREEDOM trial
20102
16 2007157
17 199940
18 199718
19
Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.
199591
20 1994197

About Socrates E. Papapoulos

Socrates E. Papapoulos is a scholar working on Orthopedics and Sports Medicine, Oncology, Nephrology, Molecular Biology and Rheumatology, having authored 303 papers that have together received 17.5k indexed citations. Recurring topics across this work include Bone health and treatments (194 papers), Bone health and osteoporosis research (141 papers), Bone Metabolism and Diseases (77 papers), Bone and Joint Diseases (59 papers), Parathyroid Disorders and Treatments (33 papers), Medical Imaging and Pathology Studies (20 papers), Cancer Diagnosis and Treatment (17 papers) and Vitamin D Research Studies (16 papers). The work is most often cited by research in Orthopedics and Sports Medicine (7.3k citations), Oncology (9.2k citations), Nephrology (1.2k citations), Rheumatology (1.9k citations) and Molecular Biology (7.3k citations). Socrates E. Papapoulos has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Clemens W.G.M. Löwik, Neveen A. T. Hamdy, Rutger L. van Bezooijen, Gabri van der Pluijm, Natasha M. Appelman‐Dijkstra, Herman A. Hamersma, Ermond van Beek, Marcel Karperien, O. L. M. Bijvoet and Martine Deckers. Their work appears in journals such as Journal of Bone and Mineral Research, Bone, Osteoporosis International, The Journal of Clinical Endocrinology & Metabolism and Calcified Tissue International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026